Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.

Attovia Therapeutics

Tao Fu

Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement.

The biparatopic binding mode of ATTOBODIES translates to picomolar affinity with glue-like off-rates, exquisite specificity, and accelerated target internalization. Their small format and modularity offer fast tissue penetration, ease of engineering into bispecifics, and tunable half-life from hours to weeks. Collectively, these properties of ATTOBODIES expand the addressable target and epitope universe across disease areas and can offer stronger efficacy, faster speed to response, and an improved safety profile compared to traditional approaches.

By utilizing our ATTOBODY technology, we will develop novel medicines that target unaddressed elements of disease, as well as offer better efficacy and tolerability. We envision a world where no patient is left behind.

Bioinformatics Organizations

Software Companies

Frazier Life Sciences

Illumina Ventures

venBio Partners

Goldman Sachs Asset Management

Cormorant Asset Management

Logos Capital

EcoR1 Capital

Nextech Ventures

Redmile Group

Marshall Wace

Fremont

City in Alameda County, California, United States

United States of America

Country primarily located in North America

San Francisco Bay Area

Metropolitan area in California, United States

California

Alameda County

Custom Computer Programming Services

Computer Systems Design and Related Services

Professional, Scientific, and Technical Services

Software Publishers

Publishing Industries

Information

Publishing Industries (except Internet)

Attovia

Alamar Biosciences

Cancer detection and treatment technology developer

Computer Programming Services

Computer Programming, Data Processing, And Other Computer Related

Business Services

Prepackaged Software

Attovia Therapeutics Funding & Investors

Total Amount Raised: $165,000,000

Attovia Therapeutics Funding Rounds

Series B Investors

Series A Investors

💸 Investors

💻 Job Types

📚 Popular Blog Posts